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Knowledge about HPV infection in the oral cavity/oropharynx may contribute to the elucidation 
of the role it plays in Head and Neck Squamous Cell Carcinoma (HNSCC).
Objective: To determine the effectiveness of the methodology used for sampling the oral cavity and 
oropharynx mucosae and to determine the prevalence of HPV in the oral cavity and oropharynx 
of adults and children.
Method: The study population was served by an assistance program in a rural district of São Paulo. 
The subjects were asked to donate samples regardless of complaints.
Results and Conclusion: The study included 47 men, 77 women and 22 children, of which the 
oral cavity samples were obtained by gargling with commercially-available antiseptic mouthwash. 
We found 3 positive samples (2.4%) in adults: 2 HPV 55 and one HPV 58. No positive results were 
found in children. Furthermore we concluded that the sampling method with the mouthwash proved 
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INTRODUCTION
Human papillomavirus (HPV) is one of the 
most common causes of sexually transmitted infections 
worldwide. Although the causal relationship between 
high-risk HPV and cervical cancer is well established1, the 
implication of this viral infection in squamous cell carci-
noma of the head and neck (HNSCC) remains uncertain. 
Brazil has one of the highest incidences of HNSCC on the 
planet, and 20,280 new cases were estimated for 20122.
Much of this lack of knowledge happens because 
there is no conclusive evidence on the prevalence of oral 
cavity infection by HPV. Existing studies resort to various 
methods, either in sampling or in the detection of HPV, 
eventually producing different results.
Based on the literature, high-risk HPV types have 
been regularly detected in 16% to 33% in oral cavity 
squamous cell carcinoma (OCSCC), 28.2% to 47% in SCC 
of the oropharynx and 13.8% to 48.5% in laryngeal SCC3.
As observed in carcinomas of the cervix, HPV + 
OCSCCs are acquired predominantly via sexual transmis-
sion4,5. However, especially in patients with laryngeal 
papillomatosis, vertical transmission from mother to fetus 
during pregnancy and childbirth may exist, indicating that 
HPV can be transmitted both sexually and non-sexually. 
HPV DNA detection in amniotic fluid, fetal membrane, 
umbilical cord and placental trophoblast cells suggest HPV 
infection in the uterus, or pre-natal6 transmission.
Since we have the availability of prevention tools 
such as the HPVvaccine7, and considering the logic that 
healthcare policies should determine in advance the impact 
of any intervention according to their cost/benefit analysis, 
we observed that there is a need to establish regional 
parameters in order to choose populations which are more 
adequate for OCSCC prevention. Knowing the continental 
dimensions of Brazil, the use of a simple, fast and effective 
way to check for HPV prevalence, it may help to lead more 
studies in different regions of the country and the world.
The objectives of this study were to investigate 
the usefulness of employing oral antiseptic mouth rinse 
in order to collect samples from the oral cavity and 
oropharynx, comparing the prevalence of HPV in the 
sample with that in the literature.
METHOD
This study was carried out with prior approval 
from the Ethics Committee on Research with protocol 
number: 419/10.
The population under study participated in the assis-
tance program conducted in 2011 in Votuporanga (latitude 
20° 25’22 “South and longitude 49° 58’22” West) in São Pau-
lo, Brazil. The entire population served by the assistance 
program was submitted to an ENT examination, regard-
less of complaints during the interview and screening. All 
patients participating in the assistance program conducted 
in the city, who were informed about the research and 
agreed to participate after signing the consent form, were 
enrolled in the program. We took off the study those who 
refused to participate in it.
Our study had men, women and children from 
4 years of age. We collected samples from the mouth 
and oropharynx cells of the patients by peeling the skin 
after rinsing and gargling with commercial oral antiseptic 
(Alcohol-free Plax and Colgate). The subjects were in-
structed to avoid consumption of any food or liquid and 
remove dentures about 30 minutes before collection. The 
participant was then instructed to rinse the oral cavity with 
a single dose of 15 ml of mouthwash, gargling vigorously 
for about 15 seconds involving the entire surface of the 
mouth. Then, the subject was told to tilt the head back and 
gargle for another 15 seconds. After this time, the solution 
was spat back to a previously labeled 50 ml conical tube.
Immediately after collection, all samples were kept 
in a refrigerator at 4°C for a maximum period of 48 hours, 
when they were transported under refrigeration to the city 
of São Paulo and processed. PCR and DNA extraction tests 
were performed according to routine protocol. The DNA 
was extracted and purified according to instructions from 
Roche’s AmpliLute Liquid Media Extraction Kit (Roche 
Diagnostics Mol, California, USA), and quantified in a full 
spectrum Nanodrop spectrophotometer. Equal amounts of 
DNA were subjected to HPV DNA detection and typing by 
polymerase chain reaction (PCR) using the Linear Array 
HPV Genotyping kit (Roche Mol Diagnostics, CA, USA). 
Biotinylated primers were used for a polymorphic region 
of 450 L1 HPV genome base pairs and another couple of 
primers for the human beta-globin gene used as DNA quality 
control, following manufacturer’s instructions. This method 
enables the detection of 37 different types of HPV and has 
been validated in several studies carried out worldwide.
RESULTS
Of the 166 individuals invited to the study, 145 
(87.3%) agreed to participate, signed a consent form and 
were included in the study. Samples were collected from 
77 adult women between 20 and 74 years of age (mean 
age ± SD = 45.3 ± 15.4), 47 adult males between 18 and 
89 years of age (mean age ± standard deviation 51.4 ± 
16.8) and 21 children between 4 and 17 years of age 
(mean age ± standard deviation 10.1 ± 4.2). Table 1 shows 
the sociodemographical characteristics of the population 
participating in the study.
The DNA was successfully isolated from all samples. 
In addition, all samples had beta-globulin, indicating good 
quality of the material submitted to PCR. Three positive results 
were obtained in adults, with a prevalence of 2.4%. The HPV 
types found were HPV 55 - in two samples and HPV 58 in 
one. No positive results were found in children (Table 2).
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Adults n (%) Children n (%)
Participants 124 21
Mean age (in years) 47.61 10.1
Gender
Males 47 (37.9) 7 (33.3)
Females 77 (62.1) 14 (66.7)
Schooling  
Illiterate 19 (15.4) 3 (14.3)
Basic Education 75 (60.5) 13 (61.9)
High School 23 (18.5) 5 (13.8)
Higher Education 7 (5.6) 0 (0)
Race
White 84 (67.7) 12 (57.1)
Black 13 (10.4) 4 (19)
Brown 27 (21.9) 4 (19)
Yellow 0 (0) 1 (4.9)
Marital Status
Single 22 (17.7) 20 (95.2)
Married 82 (66.1) 1 (4.8)
Divorcee 8 (6.4) 0 (0)
Widow(er) 12 (9.8) 0 (0)
Smoking
Yes 93 (75) 0 (0)
No 31 (31) 21 (100%)
Alcoholic beverage
Yes 46 (37.1) 2 (9.5)
No 78 (62.9) 19 (90.5)
Table 1. Sociodemographical characteristics.
Table 2. HPV DNA prevalence in oral mucosa samples.
HPV Number found n (%) Types
Adults 124 -
Positive 3 (2.4) 2 positive for type 55 1 positive for type 58
Negative 121 (97.6) -
Children 21 -
Positive 0 (0) -
Negative 21 (100) -
DISCUSSION
In a study which assessed the prevalence of HPV 
infection in the oral and oropharyngeal mucosae from 1,688 
healthy men from Mexico, USA and Brazil, the authors 
found 4% of HPV infections, and 1.3% were positive for 
HPV-16 - the most prevalent type in this population8. Con-
sidering only the adult population assessed in Votuporanga, 
the HPV prevalence was 2.4%. In the juvenile population, 
there was no HPV, an expected result, since studies show 
that the prevalence of HPV in the oral cavity of individuals 
under 18 is low - a factor that may be related to increased 
prevalence in subjects who have already started their sexual 
life9. Accordingly, in a study with 4,150 Polish children and 
adolescents between 10 and 18 years, the prevalence was 
1.08%, and HPV type 11 was the most prevalent10.
In a study carried out in Esquenazi et al.11 the 
authors evaluated 100 healthy subjects using the mouth 
brush method and found 0% prevalence of HPV. Similarly, 
in a study of 30 women who had genital warts by the 
swab method - positive samples were also not found12. In 
another study with the swab method, the authors found 
23.2% of positive samples for HPV in a population of 125 
individuals without overt oral lesions13.
Kreimer et al.8 used the same protocol for the 
collection of cell samples from the oral cavity and 
the oropharynx adopted in this study. In the study by 
Durzyńska et al.10, the method used was rinsing with 5 
ml of saline. Other studies used the swab method for 
obtaining samples11-13.
Of the three positive samples in the study, two of 
them were type 55 and one was HPV 58, coinciding with 
the types found in the papers by Kreimer et al.8, in adult 
men, and Durzyńska et al.10 in children.
The main limitations of this study are related to the 
low number of participants, the proportion of adults and 
children and the inability to characterize the population 
on habits and sexual behavior. However, the methodology 
demonstrates the feasibility of conducting a study on the 
prevalence of HPV in a region with low technological 
resources, limited time and space, with results similar to 
those available in the literature.
CONCLUSION
The collection method using rinsing with mouthwash 
was fast and effective for the detection of HPV in the oral 
cavity and oropharynx evidenced by the presence of DNA 
in all the samples and by PCR control by the beta-globulin 
gene - positive in all samples.
We found three positive (2.4%) samples for HPV 
in the oral cavity and oropharynx of the adult population 
participating in the study and no positive sample among 
the children. The HPV types found were the HPV 55 in two 
specimens, and one with HPV 58. This data is in agreement 
with the literature, showing low HPV prevalence in the 
mouth and oropharynx of healthy individuals.
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